{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:10:06Z","timestamp":1741187406889,"version":"3.38.0"},"reference-count":21,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.nephro.2007.10.001","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T00:20:01Z","timestamp":1204849201000},"page":"28-33","source":"Crossref","is-referenced-by-count":2,"title":["Traitement de l\u2019hyperparathyro\u00efdisme secondaire en dialyse\u00a0: \u00e0 propos d\u2019un cas d\u2019inefficacit\u00e9 apparente du traitement m\u00e9dicamenteux"],"prefix":"10.1684","volume":"4","author":[{"given":"Menno T.","family":"Pruijm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Teta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9goire","family":"Wuerzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Santschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2007.10.001_bib1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca \u00d7 PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2007.10.001_bib2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"8","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2007.10.001_bib3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2007.10.001_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1440-1797.2005.00476.x","article-title":"Parathyroidectomy in the calcimimetic era","volume":"10","author":"Elder","year":"2005","journal-title":"Nephrology"},{"key":"10.1016\/j.nephro.2007.10.001_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ncpneph0191","article-title":"Drug insights: renal indications of calcimimetics","volume":"2","author":"Shahapuni","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.nephro.2007.10.001_bib6","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1523-1755.2005.310_1.x","article-title":"High dialysate calcium may improve the efficacy of calcimimetic treatment in hemodialysis patients with severe hyperparathyroidism","volume":"67","author":"Touam","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2007.10.001_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1774-9987.2005.00216.x","article-title":"The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamine D metabolites","volume":"9","author":"Ando","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.nephro.2007.10.001_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mlr.0000129496.05898.02","article-title":"The concordance of self-report with other measures of medication adherence: a summary of the literature","volume":"42","author":"Garber","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.nephro.2007.10.001_bib9","first-page":"70","article-title":"Hypertension r\u00e9fractaire: attitudes et perspectives","volume":"55","author":"Burnier","year":"1997","journal-title":"Med Hyg"},{"key":"10.1016\/j.nephro.2007.10.001_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.schres.2006.11.015","article-title":"The use of electronic monitoring (MEMS\u00ae) to evaluate antipsychotic compliance in outpatients with schizophrenia","volume":"90","author":"Remington","year":"2007","journal-title":"Schizophr Res"},{"issue":"suppl 2","key":"10.1016\/j.nephro.2007.10.001_bib11","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/00004872-200305002-00007","article-title":"Monitoring compliance in resistant hypertension: an important step in patient management","volume":"21","author":"Burnier","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.nephro.2007.10.001_bib12","first-page":"307","article-title":"Hemodialysis patients\u2019 noncompliance with oral medications","volume":"26","author":"Curtin","year":"1999","journal-title":"ANNA J"},{"key":"10.1016\/j.nephro.2007.10.001_bib13","first-page":"155","article-title":"Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation","volume":"9","author":"Loghman-Adham","year":"2003","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.nephro.2007.10.001_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1525-139X.2005.18212.x","article-title":"Adherence with dialysis: a focus on mortality risk","volume":"18","author":"Leggat","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.nephro.2007.10.001_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1523-1755.2003.00064.x","article-title":"Non adherence in hemodialysis: associations with mortality, hospitalisation, and practice patterns in the DOPPS","volume":"64","author":"Saran","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2007.10.001_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0277-9536(93)90438-A","article-title":"Variation in hemodialysis patient compliance according to demographic caracteristics","volume":"37","author":"Bame","year":"1993","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.nephro.2007.10.001_bib17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1053\/ajkd.2002.33397","article-title":"Patient satisfaction with care and behavioural compliance in end-stage renal disease patients treated with hemodialysis","volume":"39","author":"Kovac","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2007.10.001_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00004872-200102000-00022","article-title":"Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions","volume":"19","author":"Burnier","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.nephro.2007.10.001_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-6143.2006.01611.x","article-title":"Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients","volume":"7","author":"Denhaerynck","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2007.10.001_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1008267104024","article-title":"Differences in older versus younger hemodialysis patients\u2019noncompliance with oral medications","volume":"7","author":"Curtin","year":"1997","journal-title":"Geriatr Nephrol Urol"},{"key":"10.1016\/j.nephro.2007.10.001_bib21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clinical Ther"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725507002349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725507002349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2007.10.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:59:35Z","timestamp":1741183175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725507002349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1769725507002349"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2007.10.001","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}